We’re happy to share that Mobiquity is collaborating with BrightInsight, who provides the leading regulated IoT platform for biopharma and medtech, and CSL Behring, a leading biotechnology company, on CSL Behring’s new digital solutions.
Earlier today, BrightInsight and CSL Behring announced a global digital health partnership to provide digitally-enhanced treatment experiences and regulated digital health offerings to support CSL Behring therapies. Mobiquity will be working alongside both companies, providing the user design and discovery work for a number of upcoming projects.
Mike Welsh, our Chief Creative Officer, shared: "We are excited to support CSL Behring’s mission and vision for patients powered by BrightInsight's industry leading platform to deliver transformative and meaningful experiences for people worldwide.”
We look forward to sharing more updates on this collaboration over the coming months.
If your organization is looking to implement new technologies that support patients, providers, payers, or any other stakeholder, Mobiquity’s healthcare experts can help. Let’s chat.
Leave your details below and we'll be in touch soon.